← Back to Tenders
United Kingdom10 days leftOpen

Plasmapheresis System to Collect Plasma for Medicines

Tender Overview

LOCATION

Gloucestershire, Wiltshire and Bristol/Bath area, United Kingdom

VALUE

£42,000,000

DEADLINE

February 13, 2026 at 00:00

CATEGORY

Other

CPV CODE

72416000

REFERENCE

008061-2026

Project Timeline

▼

Contact Information

▼
View Original

Original Tender Description

NHS Blood and Transplant (NHSBT) intends to engage with the market to inform the future procurement of plasmapheresis collection systems and associated services. NHSBT is responsible for collecting and producing Plasma for Medicine (PfM) for fractionation into plasma‑derived medicinal products for UK patients and is seeking to expand its current plasmapheresis capacity beyond its existing three donor centres. NHSBT requires access to plasmapheresis technology—including equipment, consumables, harnesses, and all supporting items—along with reliable maintenance, repair, technical support, and service continuity provisions. The purpose of this early engagement is to gather supplier insight on viable commercial approaches and routes to market. NHSBT wishes to explore a range of potential commercial models, including: - Neutral Vendor Managed Service - Managed Service Direct with Supplier / Manufacturer - Direct Purchase of Equipment and Consumables Suppliers are invited to provide feedback on the suitability, risks, benefits, and deliverability of these options, as well as suggestions for alternative solutions. Insight on scalability, supply chain resilience, operational flexibility, and total cost of ownership will support NHSBT in shaping its procurement strategy. Please contact jo.murphy@nhsbt.nhs.uk for more information.
⚠️

MANDATORY EXCLUSION GROUNDS

  • No mandatory exclusion grounds are specified for this early market engagement, as it is an information-gathering exercise.
✓

ELIGIBILITY REQUIREMENTS

  • Be a supplier capable of providing plasmapheresis collection systems and associated services.
  • Be a supplier capable of providing plasmapheresis technology, including equipment, consumables, harnesses, and all supporting items.
  • Be a supplier capable of providing reliable maintenance, repair, technical support, and service continuity provisions for plasmapheresis technology.
🔧

TECHNICAL CAPABILITY REQUIREMENTS

  • Possess the capability to provide plasmapheresis collection systems.
  • Possess the capability to provide associated services for plasmapheresis collection systems.
  • Ability to provide equipment, consumables, harnesses, and all supporting items for plasmapheresis technology.
  • Ability to provide reliable maintenance, repair, technical support, and service continuity provisions.
  • Ability to provide insight on the suitability, risks, benefits, and deliverability of various commercial models (Neutral Vendor Managed Service, Managed Service Direct with Supplier / Manufacturer, Direct Purchase of Equipment and Consumables).
  • Ability to suggest alternative commercial solutions.
  • Ability to provide insight on scalability of proposed solutions.
  • Ability to provide insight on supply chain resilience of proposed solutions.
  • Ability to provide insight on operational flexibility of proposed solutions.
💰

FINANCIAL REQUIREMENTS

  • Ability to provide insight on the total cost of ownership for plasmapheresis collection systems and associated services.
  • Ability to provide insight on viable commercial approaches and routes to market.
📋

SUBMISSION REQUIREMENTS

  • Contact jo.murphy@nhsbt.nhs.uk for more information regarding the early market engagement.
  • Provide feedback on the suitability, risks, benefits, and deliverability of the specified commercial models.
  • Provide suggestions for alternative commercial solutions.
  • Provide insight on scalability, supply chain resilience, operational flexibility, and total cost of ownership.
  • Engage with NHS Blood and Transplant to inform their future procurement strategy by the submission deadline of 2026-02-13T00:00:00.

Requirements Preview

Sign up to view complete requirements and analysis

AI-powered requirement analysis
Complete compliance breakdown
Strategic bidding insights
Instant eligibility check

No credit card required • Setup in 2 minutes

HTM
Planning Notice
Administrative Documents008061-2026.html
Summary:
NHS Blood and Transplant is conducting early market engagement to gather supplier insights on commercial approaches and solutions for the future procurement of plasmapheresis collection systems and associated services, aiming to expand its capacity.
DOC
OCDS Record
OCDS Data008061-2026_ocds_record.json
Summary:
NHS Blood and Transplant is conducting early market engagement to gather supplier insights on plasmapheresis collection systems and associated services, exploring various commercial models to expand capacity.
DOC
OCDS Release Package
OCDS Data008061-2026_ocds_release.json
Summary:
NHS Blood and Transplant is conducting early market engagement to gather supplier insights on commercial models for plasmapheresis collection systems and associated services, aiming to shape a future procurement strategy.
PDF
Official PDF Version
Administrative Documents008061-2026_official.pdf
Summary:
NHS Blood and Transplant is conducting preliminary market engagement to gather supplier insights on viable commercial approaches for the future procurement of plasmapheresis collection systems and associated services, with an estimated value of £35-42 million.

Documents Preview

Sign up to view document summaries and analysis

AI document summaries
Key requirement extraction
Risk & compliance alerts
Strategic document insights

No credit card required • Setup in 2 minutes

72
Good

Tender Quality Score

This early market engagement notice is clear and transparent regarding its purpose and requirements for supplier insight, but it suffers from a critical CPV code mismatch and lacks modern e-submission and sustainability considerations.

Score Breakdown

Legal Compliance60/100

The primary concern is the incorrect CPV code (72416000 - Application service providers) for a plasmapheresis system, which can severely hinder the visibility of this early market engagement to relevant suppliers. While it's an RFI, proper classification is crucial for market reach. The procedure type is appropriately undefined for an early engagement, and deadlines are reasonable for this stage.

•Incorrect CPV code assigned.
Clarity90/100

The purpose, scope, and requested insights for this early market engagement are exceptionally clear and unambiguous. The AI-extracted requirements accurately reflect the description and are easy to understand. The absence of formal evaluation criteria is appropriate for an information-gathering phase.

Completeness85/100

All essential basic information, including title, reference, organization, estimated value, duration, and location, is provided. Requirements for supplier insight are well-defined. The four associated documents are listed. The lack of formal evaluation criteria is expected for an early market engagement.

•"Liable Person" field is empty.
Fairness70/100

The requirements are generic and not tailored, promoting broad participation. The estimated value is disclosed, and deadlines are reasonable for an RFI. However, the absence of electronic submission (e-submission) is a significant drawback, potentially creating barriers for some suppliers and reducing efficiency and equal access.

•No e-submission support.
Practicality65/100

The primary practical concern is the lack of electronic submission, which can complicate the process for both the procuring entity and potential suppliers. A direct contact email is provided, which is practical for an RFI. Contract start and duration are clearly specified.

•No e-submission support.
Data Consistency90/100

Key fields are largely populated, and the data presented is consistent. There are no reported disputes or suspensions, and the timeline (submission deadline before contract start) is logical for a planning phase.

•"Liable Person" field is empty.
Sustainability20/100

The tender completely lacks any mention of green procurement, social aspects, or a specific focus on innovation beyond exploring commercial models. This represents a significant missed opportunity to integrate modern sustainability and responsible procurement principles.

•No green procurement criteria.
•No social criteria.

Strengths

Clear and detailed description of the early market engagement purpose.
Well-defined requirements for supplier insights.
Transparency regarding estimated value and contract duration.
Good data consistency and logical timeline for planning.
Generic requirements, not tailored to specific companies.

Concerns

Incorrect CPV code, potentially limiting market reach.
Absence of electronic submission for responses.
Complete lack of sustainability (green, social) and innovation criteria.
"Liable Person" field is empty.

Recommendations

1. Correct the CPV code to accurately reflect the nature of plasmapheresis systems and services to ensure proper market visibility.
2. Implement an e-submission platform for future engagements and the formal tender to enhance fairness and efficiency.
3. Integrate sustainability criteria (environmental, social, innovation) into the future procurement strategy and formal tender documents.

AI Scoring Preview

Sign up to view complete requirements and analysis

Complete quality score analysis
Detailed sub-score breakdown
Strengths & concerns insights
Strategic recommendations

No credit card required • Setup in 2 minutes

Generate DocumentsReview Documents
B
Tender Quality Score
72/ 100 · Good
→

Tender Assistant

Ask me anything about this tender

Tender Assistant

Hello! I'm your AI assistant for this tender. I can help you understand requirements, deadlines, eligibility criteria, and provide strategic insights.

What are the main requirements?
When is the deadline?
Who is eligible to bid?

No credit card required

Setup in 2 minutes

Save with Notes